CIK: 0001583977 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $2,093,868 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 8,494,151 | $512,962 | 24.5% | $12.22 | +321.7% | CLASS A ORD | 61559X104 |
| — | AMBRX BIOPHARMA INC | 11,231,000 | $159,929 | 7.6% | $14.24 | — | COM | 641871108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 6,038,235 | $139,544 | 6.7% | $8.40 | +33.1% | COM NEW | 30233G209 |
| BBIO | BRIDGEBIO PHARMA INC | 3,344,179 | $135,005 | 6.4% | $17.77 | +69.0% | COM | 10806X102 |
| ACLX | ARCELLX INC | 1,700,000 | $94,350 | 4.5% | $21.44 | +110.4% | COMMON STOCK | 03940C100 |
| — | RAYZEBIO INC | 1,213,478 | $75,442 | 3.6% | $23.23 | — | COM | 75525N107 |
| BMEA | BIOMEA FUSION INC | 3,570,872 | $51,849 | 2.5% | $17.07 | -28.8% | COM | 09077A106 |
| IMVT | IMMUNOVANT INC | 1,165,000 | $49,081 | 2.3% | $20.83 | +76.7% | COM | 45258J102 |
| — | ALPINE IMMUNE SCIENCES INC | 2,550,000 | $48,603 | 2.3% | $13.39 | — | COM | 02083G100 |
| PHVS | PHARVARIS N V | 1,711,460 | $48,006 | 2.3% | $21.48 | -5.8% | COM | N69605108 |
| ALXO | ALX ONCOLOGY HLDGS INC | 3,142,079 | $46,786 | 2.2% | $15.94 | -40.5% | COM | 00166B105 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,221,422 | $44,984 | 2.1% | $21.36 | -21.8% | COM | 87650L103 |
| — | CYMABAY THERAPEUTICS INC | 1,800,000 | $42,516 | 2.0% | $7.39 | — | COM | 23257D103 |
| PCVX | VAXCYTE INC | 665,000 | $41,762 | 2.0% | $44.03 | +18.0% | COM | 92243G108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,150,000 | $40,917 | 2.0% | $21.03 | +45.8% | COM | 22663K107 |
| APLS | APELLIS PHARMACEUTICALS INC | 625,000 | $37,413 | 1.8% | $42.18 | +20.3% | COM | 03753U106 |
| — | MARINUS PHARMACEUTICALS INC | 3,250,000 | $35,328 | 1.7% | $8.59 | — | COM NEW | 56854Q200 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 5,450,000 | $35,098 | 1.7% | $8.24 | — | SPON ADS | 05280R100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 2,456,800 | $34,469 | 1.6% | $25.80 | -47.9% | COM | 68062P106 |
| IMRX | IMMUNEERING CORP | 4,204,364 | $30,902 | 1.5% | $18.88 | -64.7% | CLASS A COM | 45254E107 |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,551,989 | $27,919 | 1.3% | $25.59 | -72.6% | COM | 28036F105 |
| — | AEROVATE THERAPEUTICS INC | 1,211,696 | $27,421 | 1.3% | $20.58 | — | COM | 008064107 |
| — | CARGO THERAPEUTICS INC | 1,182,563 | $27,376 | 1.3% | $23.15 | — | COM | 14179K101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,175,000 | $25,392 | 1.2% | $15.37 | 0.0% | COM | 87164F105 |
| KRRO | KORRO BIO INC | 529,170 | $25,363 | 1.2% | $32.95 | 0.0% | COM | 500946108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 550,000 | $25,284 | 1.2% | $19.33 | +63.2% | COM | 76243J105 |
| ABVX | ABIVAX SA | 2,130,000 | $22,791 | 1.1% | $10.70 | — | SPONSORED ADS | 00370M103 |
| — | HARPOON THERAPEUTICS INC | 2,349,060 | $22,551 | 1.1% | $9.47 | — | COM NEW | 41358P205 |
| SYRE | SPYRE THERAPEUTICS INC | 937,080 | $20,166 | 1.0% | $13.78 | 0.0% | COM NEW | 00773J202 |
| INSM | INSMED INC | 575,000 | $17,819 | 0.9% | $22.87 | +13.4% | COM PAR $.01 | 457669307 |
| IDYA | IDEAYA BIOSCIENCES INC | 450,000 | $16,011 | 0.8% | $16.14 | +84.9% | COM | 45166A102 |
| — | AXONICS INC | 250,000 | $15,558 | 0.7% | $15.11 | — | COM | 05465P101 |
| NGNE | NEUROGENE INC | 746,180 | $14,461 | 0.7% | $14.32 | 0.0% | COM | 64135M105 |
| — | LONGBOARD PHARMACEUTICALS IN | 2,353,141 | $14,189 | 0.7% | $14.21 | — | COM | 54300N103 |
| PRAX | PRAXIS PRECISION MEDICINES I | 633,345 | $14,111 | 0.7% | $18.01 | 0.0% | COM NEW | 74006W207 |
| RCKT | ROCKET PHARMACEUTICALS INC | 450,000 | $13,487 | 0.6% | $16.47 | +34.0% | COM | 77313F106 |
| — | RAPT THERAPEUTICS INC | 496,750 | $12,344 | 0.6% | $8.60 | — | COM | 75382E109 |
| IRON | DISC MEDICINE INC | 125,000 | $7,220 | 0.3% | $35.48 | +44.3% | COM | 254604101 |
| STOK | STOKE THERAPEUTICS INC | 1,087,807 | $5,722 | 0.3% | $26.85 | -84.1% | COM | 86150R107 |
| EDIT | EDITAS MEDICINE INC | 500,000 | $5,065 | 0.2% | — | — | Put | 28106W103 |
| — | VERVE THERAPEUTICS INC | 350,000 | $4,879 | 0.2% | $49.89 | — | COM | 92539P101 |
| LNTH | LANTHEUS HLDGS INC | 75,000 | $4,650 | 0.2% | $67.75 | 0.0% | COM | 516544103 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 561,600 | $4,470 | 0.2% | $15.97 | — | SPONSORED ADS | 152309100 |
| BHVN | BIOHAVEN LTD | 81,963 | $3,508 | 0.2% | $14.12 | +120.2% | COM | G1110E107 |
| GHRS | GH RESEARCH PLC | 593,043 | $3,440 | 0.2% | $20.43 | -65.4% | ORDINARY SHARES | G3855L106 |
| VYNE | VYNE THERAPEUTICS INC | 1,394,336 | $3,249 | 0.2% | $3.12 | 0.0% | COM | 92941V308 |
| BCAB | BIOATLA INC | 1,181,115 | $2,906 | 0.1% | $19.72 | -91.2% | COM | 09077B104 |
| NMRA | NEUMORA THERAPEUTICS INC. | 92,293 | $1,574 | 0.1% | $12.87 | -4.6% | COM | 640979100 |